The Next Drugs: An Atlantic Policy Update on Biosimilars

07 June 2017 Washington, DC Past Event

Location

Washington, DC

Agenda

8:00 a.m. - 10:00 a.m. Eastern

As part of the live broadcast series by AtlanticLive titled “The Next Drugs: An Atlantic Policy Update on Biosimilar”, Foley partner Courtenay Brinckerhoff will join the panel of speakers to address the current Supreme Court case on the patent dance, intellectual property and exclusivity issues, and the way forward.

The speakers include:

  • Courtenay Brinckerhoff, Partner, Foley & Lardner LLP
  • Phil Nickson, Associate General Counsel for IP, Momenta Pharmaceuticals
  • Representative Peter Welch (D-VT)
  • Steve Clemons, Washington Editor at Large, The Atlantic
  • Olga Khazan, Staff Writer, The Atlantic

For more information and to register, please visit AtlanticLive’s website.

Insights

CMS Proposes Enhanced Scrutiny over Medicaid Supplemental Payments
20 November 2019
Health Care Law Today
The Purpose of a Corporation
November 2019
Legal News: Business Law
Should This Be a "Mobility" Industry Blog?
19 November 2019
Dashboard Insights
Data Processing Patent Eligibility: Federal Circuit Finds Claims Eligible in KPN v. Gemalto
19 November 2019
IP Litigation Current
PATH Summit 2019
18-20 December 2019
Arlington, VA
Madison CLE Days
18-19 December 2019
Madison, WI
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
HFMA MA-RI Annual Compliance Update
12 December 2019
Boston, MA

The Next Drugs: An Atlantic Policy Update on Biosimilars

Location

Washington, DC

Agenda

8:00 a.m. - 10:00 a.m. Eastern